Severe pulmonary arterial hypertension associated with congenital cardiac shunts: evolution under specific treatment.

R I Negoi, I Ghiorghiu, F Filipoiu, M Hostiuc, I Negoi, C Ginghina

Open access · greenAbstract readObservational Study

In one paragraph

Observational study in Journal of medicine and life. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it

0cells of the map it votes in

1citing papers in PubMed

0.2field-weighted citation impact, top 36% of its field

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

Effects of PDE-5 Inhibition on the Cardiopulmonary System After 2 or 4 Weeks of Chronic Hypoxia.Cardiovascular drugs and therapy · 2019
Article

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

R I NegoiAnatomy Department, "Carol Davila" University of Medicine and Pharmacy, Bucharest, Romania.

I GhiorghiuCardiology Department, "C.C. Iliescu" Institute for Emergencies in Cardiovascular Diseases, Bucharest, Romania; "Carol Davila" University of Medicine and Pharmacy, Bucharest, Romania.

F FilipoiuAnatomy Department, "Carol Davila" University of Medicine and Pharmacy, Bucharest, Romania.

M HostiucInternal Medicine Department, Emergency Hospital of Bucharest, Bucharest, Romania; "Carol Davila" University of Medicine and Pharmacy, Bucharest, Romania.

I NegoiGeneral Surgery Department, Emergency Hospital of Bucharest, Bucharest, Romania; "Carol Davila" University of Medicine and Pharmacy, Bucharest, Romania.

C GinghinaCardiology Department, "C.C. Iliescu" Institute for Emergencies in Cardiovascular Diseases, Bucharest, Romania; "Carol Davila" University of Medicine and Pharmacy, Bucharest, Romania.

Carol Davila University of Medicine and Pharmacy · RO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AdolescentAdultAntihypertensive AgentsBlood PressureBosentanDrug Therapy, CombinationElectrocardiographyFemaleHeart Defects, CongenitalHumansHypertension, PulmonaryKaplan-Meier EstimateMaleMiddle AgedOxygenProspective StudiesAntihypertensive AgentsBosentanOxygenSildenafil CitrateSulfonamidescongenital cardiac shuntspulmonary arterial hypertensionspecific therapy

Identifiers

PMID28616089

PMCPMC5467254

OpenAlexW2975048693

What Socratic holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.